Why your liver is the ‘canary in the coal mine’ for health

It’s the most common liver ailment in the country, but treatment is limited to diet and exercise. Researchers are now looking ...

Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of ...

BrYet Files IND Application for ML-016, Lead Oncology Therapeutic for Advanced Solid Tumors with Lung and/or Liver Metastases

ML-016 is comprised of an amino acid polymer conjugated to doxorubicin with a formulation that includes BrYet's proprietary ...

Injectable 'satellite livers' could offer an alternative to liver transplantation

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...